Demleitner AF - Search Results

1

[Smell the smoke before one sees the fire-The oligosymptomatic prodromal phase of neurodegenerative diseases].

Wolff A, Demleitner AF, Feneberg E, Lingor P. Wolff A, et al. Among authors: demleitner af. Nervenarzt. 2024 Apr 17. doi: 10.1007/s00115-024-01654-0. Online ahead of print. Nervenarzt. 2024. PMID: 38630299 Review. German.

2

Unraveling the Heterogeneity of ALS-A Call to Redefine Patient Stratification for Better Outcomes in Clinical Trials.

Tzeplaeff L, Jürs AV, Wohnrade C, Demleitner AF. Tzeplaeff L, et al. Among authors: demleitner af. Cells. 2024 Mar 5;13(5):452. doi: 10.3390/cells13050452. Cells. 2024. PMID: 38474416 Free PMC article. Review.

3

Reduced tear fluid production in neurological diseases: a cohort study in 708 patients.

Luib E, Demleitner AF, Cordts I, Westenberg E, Rau P, Pürner D, Haller B, Lingor P. Luib E, et al. Among authors: demleitner af. J Neurol. 2024 Apr;271(4):1824-1836. doi: 10.1007/s00415-023-12104-3. Epub 2023 Dec 8. J Neurol. 2024. PMID: 38063868 Free PMC article.

4

Long-Lasting Impact of the COVID-19 Pandemic on Patients with Parkinson's Disease and Their Relatives.

Wolff AW, Haller B, Demleitner AF, Pürner D, Niederschweiberer J, Cordts I, Westenberg E, Lingor P. Wolff AW, et al. Among authors: demleitner af. Mov Disord Clin Pract. 2023 Apr 12;10(5):819-823. doi: 10.1002/mdc3.13727. eCollection 2023 May. Mov Disord Clin Pract. 2023. PMID: 37205245 Free PMC article.

5

Parkinson's disease therapy: what lies ahead?

Wolff A, Schumacher NU, Pürner D, Machetanz G, Demleitner AF, Feneberg E, Hagemeier M, Lingor P. Wolff A, et al. Among authors: demleitner af. J Neural Transm (Vienna). 2023 Jun;130(6):793-820. doi: 10.1007/s00702-023-02641-6. Epub 2023 May 5. J Neural Transm (Vienna). 2023. PMID: 37147404 Free PMC article. Review.

6

SARS-CoV-2 and neurodegenerative diseases: what we know and what we don't.

Lingor P, Demleitner AF, Wolff AW, Feneberg E. Lingor P, et al. Among authors: demleitner af. J Neural Transm (Vienna). 2022 Sep;129(9):1155-1167. doi: 10.1007/s00702-022-02500-w. Epub 2022 Apr 17. J Neural Transm (Vienna). 2022. PMID: 35434769 Free PMC article. Review.

7

Impact of the COVID-19 Pandemic on Patients with Parkinson's Disease from the Perspective of Treating Physicians-A Nationwide Cross-Sectional Study.

Wolff AW, Haller B, Demleitner AF, Westenberg E, Lingor P. Wolff AW, et al. Among authors: demleitner af. Brain Sci. 2022 Mar 5;12(3):353. doi: 10.3390/brainsci12030353. Brain Sci. 2022. PMID: 35326309 Free PMC article.

8

Best practice approaches to outpatient management of people living with Parkinson's disease during the COVID-19 pandemic.

Demleitner AF, Wolff AW, Erber J, Gebhardt F, Westenberg E, Winkler AS, Kolbe-Busch S, Chaberny IF, Lingor P. Demleitner AF, et al. J Neural Transm (Vienna). 2022 Nov;129(11):1377-1385. doi: 10.1007/s00702-022-02484-7. Epub 2022 Mar 4. J Neural Transm (Vienna). 2022. PMID: 35244753 Free PMC article.

9

Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan.

Ikenberg B, Demleitner AF, Thiele T, Wiestler B, Götze K, Mößmer G, Lingor P. Ikenberg B, et al. Among authors: demleitner af. Stroke Vasc Neurol. 2021 Dec;6(4):668-670. doi: 10.1136/svn-2021-001095. Epub 2021 Jul 8. Stroke Vasc Neurol. 2021. PMID: 34244448 Free PMC article.

10

Pumilio2 and Staufen2 selectively balance the synaptic proteome.

Schieweck R, Riedemann T, Forné I, Harner M, Bauer KE, Rieger D, Ang FY, Hutten S, Demleitner AF, Popper B, Derdak S, Sutor B, Bilban M, Imhof A, Kiebler MA. Schieweck R, et al. Among authors: demleitner af. Cell Rep. 2021 Jun 22;35(12):109279. doi: 10.1016/j.celrep.2021.109279. Cell Rep. 2021. PMID: 34161769 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page